Always approachable and supportive.
Dr David Lindsay serves as Senior Lecturer in Pure and Applied Chemistry at the University of Strathclyde. His work centres on organic synthesis, organometallic chemistry, catalysis, and reaction mechanisms, with particular emphasis on iridium-catalysed hydrogen isotope exchange and C–H activation processes. Recent research outputs include the 2026 paper titled “Targeting activin receptor-like kinase 2 using heterobifunctional protein degraders” published in the Journal of Medicinal Chemistry, the 2026 paper “Widely-used boronic esters as synthetically-versatile directing groups for C–H activation and hydrogen isotope exchange” in Chemical Science, and the 2025 paper “A mild and efficient iridium-catalysed method for aldimine hydrogenation” in Advanced Synthesis and Catalysis. He has delivered invited lectures on topics such as new catalytic approaches for isotopically-labelled architectures and iridium catalysts for C(sp3)–H hydrogen isotope exchange. Dr Lindsay acts as co-investigator on multiple EPSRC-funded projects, including the 2025–2030 UKRI DA EPSRC IDLA scheme and several Industrial CASE accounts focused on the design and synthesis of next-generation molecules. He maintains an active research group collaborating closely with colleagues on asymmetric synthesis and medicinal chemistry applications.
